Sysmex (OTCMKTS:SSMXY) Shares Gap Down – Here’s Why

Sysmex Corporation ADR (OTCMKTS:SSMXY)’s stock price gapped down before the market opened on Wednesday . The stock had previously closed at $8.50, but opened at $8.16. Sysmex shares last traded at $8.53, with a volume of 1,667 shares traded.

Analyst Ratings Changes

Separately, Citigroup cut Sysmex from a “strong-buy” rating to a “hold” rating in a research note on Monday, March 16th. One analyst has rated the stock with a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Hold”.

Sysmex Stock Performance

The stock has a market cap of $5.29 billion, a PE ratio of 17.50 and a beta of 1.14. The stock has a fifty day moving average of $9.14 and a 200-day moving average of $10.28. The company has a quick ratio of 2.44, a current ratio of 3.33 and a debt-to-equity ratio of 0.12.

Sysmex (OTCMKTS:SSMXY) last posted its quarterly earnings data on Thursday, February 12th. The company reported $0.15 earnings per share for the quarter, topping analysts’ consensus estimates of $0.14 by $0.01. Sysmex had a return on equity of 9.27% and a net margin of 8.86%.The company had revenue of $837.32 million during the quarter, compared to analysts’ expectations of $819.99 million. On average, equities analysts forecast that Sysmex Corporation ADR will post 0.57 EPS for the current year.

About Sysmex

Sysmex Corporation (OTCMKTS: SSMXY) is a Japan‐based provider of in vitro diagnostic solutions, specializing in haematology, coagulation, urinalysis and immunochemistry systems. Headquartered in Kobe, the company designs and manufactures a comprehensive portfolio of automated analyzers, reagents and software to support clinical laboratories, hospitals and research institutions. Sysmex’s product lineup also includes digital pathology platforms and data management tools that integrate workflow automation and advanced analytics.

The company’s core offerings center on haematology analyzers such as the XN-Series, which deliver high‐speed, high‐volume testing for blood cell counts and differential analysis.